Answers are grounded in this paper and cite their sources.
The systematic review by Azzopardi et al 1 assesses participation by Asian patients in seminal cardiometabolic trials during the preceding decade.The authors find that the proportion of enrolled Asian participants was 8.3%, which they describe as significant under-representation.
No takes yet. Share an insight, caveat, or question.
Akshay Pendyal (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: